slidebg1

International e- Journal of Diabetes (IEJD) is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to diabetes. The primary purpose of International e Journal of Diabetes and its Complications is to act as a source of information, usable by those caring for patients with diabetes mellitus. While our primary aim is to assist the practitioner in his/her care of such patients, and to afford access to information that may allow the prevention of such complications, it is the Editors' wish to function as a forum for that information which, while still experimental, may shed light upon current thinking of those active in the fields appropriate to the aims of International e Journal of Diabetes and its Complications.

The potential scope of diabetes is broad, and we expect it to eventually involve all aspects of medicine in addition to general articles on clinical aspects of diabetes mellitus, International e Journal of Diabetes and its Complications also presents articles on basic research in all areas of diabetes and its related subjects. Topics covered relevant to the diabetic patient will include diagnosis, pathogenesis, and clinical management of diabetic retinopathy, neuropathy and nephropathy peripheral vascular disease and coronary heart disease, gastrointestinal disorders, renal failure and impotence, hypertension and hyperlipidemia. Journal of Diabetes and its Complications will also publish papers on the general pathogenesis and prevention of diabetes.

International e Journal of Diabetes aims to publish original research papers, Mini Reviews, Short Communications, Case Reports, Image review articles, survey articles, and projects reviews in all areas dedicated to biological Research. (Single-point manuscripts that report original research with conceptual or practical advances that are of broad interest to biologists and clinicians) As a peer reviewed journal, it is positioned to promote research and educational development in the rapidly evolving field of diabetes research around the world.


We do accept:
1) Short reports - 2-5 page papers where an author can present either an idea with theoretical background but has not yet completed the research needed for a complete paper or preliminary data.
2) Book reviews - Comments and critiques.

All manuscripts will be peer-reviewed with experts in the relevant fields and will be published within 2 months of submission if accepted. Also, systematic reviews of clinical and basic research, as well as clinical practice guidelines, are especially welcome.

All the content published with us is open and freely accessible under the guidelines of Creative Common Attribution License.